Head and neck mucosal squamous cell carcinoma: results of palliative management.
Select Content Type
Clinical Guidelines
Authored By
C Timon, K Reilly
Authored On
Interests
Pulmonology
Oncology
Speciality
Oncology
Pulmonology
Book Detail
volume
120
ISSN
00222151
Publication Date
Actions
Download in App
Event Data
{"article_title":"Lung metastases radiation therapy.","author":"L\u00e9vy A, Darr\u00e9on J, Mornex F, Giraud P, Thureau S","journal_title":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","issn":"1769-6658","isbn":"","publication_date":"2022-02-01","volume":"26","issue":"1-Feb","first_page":"244","page_count":"","accession_number":"34953714","doi":"10.1016\/j.canrad.2021.08.011","publisher":"Elsevier","doctype":"Journal Article","subjects":"France; Lung Neoplasms radiotherapy; Lung Neoplasms secondary; Radiosurgery; Radiotherapy, Conformal; Dose Fractionation, Radiation; France; Humans; Organs at Risk radiation effects; Palliative Care methods; Radiation Oncology; Radiotherapy Dosage; Radiotherapy, Image-Guided","interest_area":["Pulmonology"," Oncology"],"abstract":"We present an update of the French society of oncological radiotherapy recommendation regarding indication, doses, and technique of radiotherapy for intrathoracic metastases. The recommendations for delineation of the target volumes and critical organs are detailed. Copyright \u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=34953714","isPdfLink":false,"isSAML":true,"an":"34953714","number_other":"","type_pub":"","issn_electronic":"1769-6658","languages":"English","language":"eng","date_entry":"Date Created: 20211226 Date Completed: 20220217 Latest Revision: 20220217","date_update":"20240104","titleSource":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2022 Feb-Apr; Vol. 26 (1-2), pp. 244-249. Date of Electronic Publication: 2021 Dec 23.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-02-01","description":"We present an update of the French society of oncological radiotherapy recommendation regarding indication, doses, and technique of radiotherapy for intrathoracic metastases. The recommendations for delineation of the target volumes and critical organs are detailed.<br \/> (Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)","upload_link":"https:\/\/dx.doi.org\/doi:10.1017\/S0022215106000740","no_of_pages":"","authored_by":"L\u00e9vy A, Darr\u00e9on J, Mornex F, Giraud P, Thureau S","additionalInfo":{"Authored_By":"C Timon, K Reilly","Published_Date":"2006-05-01","Source":"Journal of Laryngology & Otology; May2006, Vol. 120 Issue 5, p389-392, 4p","Languages":"English","Subjects":"CANCER patients, CHILDREN of cancer patients, HOSPICE care","Title_Abbreviations":"Journal of Laryngology & Otology","Volume":"120"},"header":{"DbId":"edb","DbLabel":"Complementary Index","An":"34953714","RelevancyScore":"833","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"832.625671386719"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=edb&AN=34953714&authtype=shib&custid=ns346513&group=main&profile=eds"}
["C Timon, K Reilly","2006-05-01","Journal of Laryngology & Otology; May2006, Vol. 120 Issue 5, p389-392, 4p","English","CANCER patients, CHILDREN of cancer patients, HOSPICE care","Journal of Laryngology & Otology","120"]
Description
Objective: To document the outcome of patients deemed at initial diagnosis to be appropriate for palliative care.Materials and methods: Over a five-year period, all patients with head and neck mucosal squamous cell carcinoma (HNMSCC) were referred to one consultant surgeon, and data were collated retrospectively.Results: Of 286 patients with HNMSCC, 60 (21 per cent) were deemed appropriate for palliative care at initial diagnosis. Their median survival was 154 days, with hypopharyngeal and oropharyngeal tumours forming a disproportional percentage of the initial diagnoses (p < 0.001). After initial assessment, 66 per cent of patients were discharged to their home, 17 per cent to hospice care and 17 per cent were transferred to other institutions. Including deaths during the initial admission, 29 per cent of patients did not return home after diagnosis. Palliative treatment included operative interventions in 35 per cent and radiotherapy in 43 per cent. Time spent in further hospital care averaged 47 days, and 47 per cent of patients eventually died in hospital.Conclusion: One in five patients presenting with HNMSCC were deemed appropriate for palliative care at initial presentation and survived less than six months after diagnosis. More than one-third required surgical intervention, and 29 per cent never returned home. [ABSTRACT FROM AUTHOR]
